199 related articles for article (PubMed ID: 30602509)
1. Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular
Khalil ZG; Hill TA; De Leon Rodriguez LM; Lohman RJ; Hoang HN; Reiling N; Hillemann D; Brimble MA; Fairlie DP; Blumenthal A; Capon RJ
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602509
[TBL] [Abstract][Full Text] [Related]
2. Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis.
Rollo RF; Mori G; Hill TA; Hillemann D; Niemann S; Homolka S; Fairlie DP; Blumenthal A
Microbiol Spectr; 2023 Aug; 11(4):e0046523. PubMed ID: 37289062
[TBL] [Abstract][Full Text] [Related]
3. An efficient synthetic route for preparation of antimycobacterial wollamides and evaluation of their in vitro and in vivo efficacy.
Asfaw H; Wetzlar T; Martinez-Martinez MS; Imming P
Bioorg Med Chem Lett; 2018 Sep; 28(17):2899-2905. PubMed ID: 30031620
[TBL] [Abstract][Full Text] [Related]
4. Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs.
Tsutsumi LS; Elmore JM; Dang UT; Wallace MJ; Marreddy R; Lee RB; Tan GT; Hurdle JG; Lee RE; Sun D
ACS Comb Sci; 2018 Mar; 20(3):172-185. PubMed ID: 29431987
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent.
Asfaw H; Laqua K; Walkowska AM; Cunningham F; Martinez-Martinez MS; Cuevas-Zurita JC; Ballell-Pages L; Imming P
PLoS One; 2017; 12(4):e0176088. PubMed ID: 28423019
[TBL] [Abstract][Full Text] [Related]
6. Solid-Phase Synthesis of Wollamide Cyclohexapeptide Analogs.
Prior AM; Sun D
Methods Mol Biol; 2020; 2103():175-187. PubMed ID: 31879925
[TBL] [Abstract][Full Text] [Related]
7. Wollamides: antimycobacterial cyclic hexapeptides from an Australian soil Streptomyces.
Khalil ZG; Salim AA; Lacey E; Blumenthal A; Capon RJ
Org Lett; 2014 Oct; 16(19):5120-3. PubMed ID: 25229313
[TBL] [Abstract][Full Text] [Related]
8. Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs.
Chen YX; Liu C; Liu N; Wu Y; Zhao QJ; Hu HG; Li X; Zou Y
Chem Biodivers; 2018 Jan; 15(1):. PubMed ID: 29125222
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
[TBL] [Abstract][Full Text] [Related]
10. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
12. Enhanced susceptibility of multidrug resistant strains of Mycobacterium tuberculosis to granulysin peptides correlates with a reduced fitness phenotype.
Toro JC; Hoffner S; Linde C; Andersson M; Andersson J; Grundström S
Microbes Infect; 2006 Jul; 8(8):1985-93. PubMed ID: 16793311
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
Rastogi N; Labrousse V; Goh KS
Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis.
Upton AM; Cho S; Yang TJ; Kim Y; Wang Y; Lu Y; Wang B; Xu J; Mdluli K; Ma Z; Franzblau SG
Antimicrob Agents Chemother; 2015 Jan; 59(1):136-44. PubMed ID: 25331696
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.
Wen S; Jing W; Zhang T; Zong Z; Xue Y; Shang Y; Wang F; Huang H; Chu N; Pang Y
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1293-1296. PubMed ID: 30953211
[TBL] [Abstract][Full Text] [Related]
16. Comparison of
Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
[TBL] [Abstract][Full Text] [Related]
17. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
[TBL] [Abstract][Full Text] [Related]
18. 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Karabanovich G; Roh J; Smutný T; Němeček J; Vicherek P; Stolaříková J; Vejsová M; Dufková I; Vávrová K; Pávek P; Klimešová V; Hrabálek A
Eur J Med Chem; 2014 Jul; 82():324-40. PubMed ID: 24927053
[TBL] [Abstract][Full Text] [Related]
19. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
[TBL] [Abstract][Full Text] [Related]
20. Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Gold B; Smith R; Nguyen Q; Roberts J; Ling Y; Lopez Quezada L; Somersan S; Warrier T; Little D; Pingle M; Zhang D; Ballinger E; Zimmerman M; Dartois V; Hanson P; Mitscher LA; Porubsky P; Rogers S; Schoenen FJ; Nathan C; Aubé J
J Med Chem; 2016 Jul; 59(13):6027-44. PubMed ID: 27144688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
